Public Health
Latest news
508 articles · 20 / page
Ecolabels and the Impact on Healthfulness and Carbon Footprint of Restaurant Meal Choices: A Randomized Clinical Trial
This clinical trial found that ecolabels on restaurant menus can reduce the carbon footprint of meals without compromising nutritional quality, highlighting ecolabels as a promising low-cost strategy for sustainable dining.
Does Using Your Phone While Charging Increase Radiation? Unpacking the Science and Safety
Explore how phone charging affects electromagnetic radiation levels, what this means for health, and practical tips to reduce exposure while keeping your device safe.
Unveiling the Hidden Risks of 5G Radiation: Impacts on Male Fertility
Recent animal studies suggest daily 5G phone radiation exposure may significantly impair sperm quality, raising concerns over modern lifestyle and reproductive health.
Technology, Ethics, and Equity: Navigating the Three Core Challenges in Large-Scale Genomic Newborn Screening for Universal Health Benefits
Genomic newborn screening shows promise for early detection of a wider range of diseases but raises significant technological, ethical, and equity challenges before becoming a universally accessible public health tool.
Hospital Addiction Consult Services: A Promising Step to Reduce Emergency Visits Among Patients with Opioid Use Disorder
A hospital-based addiction consult program lowered emergency department visits in opioid use disorder patients but did not reduce hospitalizations or mortality, highlighting the need for comprehensive care beyond hospital walls.
Impact of Physician-Personalized Videos and Infographics on Influenza Vaccination Rates: Findings from a Randomized Clinical Trial
This trial assessed if videos and infographics from primary care physicians improve flu vaccination rates; overall effects were minimal, but notable improvements occurred in children.
Impact of Graphic Health Warnings on Little Cigar and Cigarillo Use: Evidence from a Randomized Clinical Trial
A randomized trial demonstrates that graphic health warnings on little cigars and cigarillos significantly increase quitting intentions and related behaviors compared to FDA text-only warnings or no warnings, highlighting the need for enhan
Impact of a $40 Monthly Healthy Food Benefit on Food Security and Fruit and Vegetable Intake in Lower-Income Populations
A cohort study found that a $40 monthly healthy food benefit program significantly improved food security and increased the frequency of fruit and vegetable consumption among lower-income urban adults, highlighting its potential to reduce n
Optimizing Hepatitis C Screening in Emergency Departments: Insights from the DETECT Hep C Randomized Clinical Trial
The DETECT Hep C trial demonstrates nontargeted HCV screening in emergency departments identifies more new infections than risk-based approaches, though linkage to care remains suboptimal, underscoring the need for innovative treatment mode
The Dawn of the “No-Clinical-Trial” Era for Biosimilars: FDA’s Historic Ustekinumab Approval Shift
The US FDA’s unprecedented exemption of clinical efficacy studies for a ustekinumab biosimilar marks a transformative regulatory milestone, reshaping biosimilar development, market dynamics, and patient access worldwide.
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults: Insights from the DANFLU-2 Randomized Clinical Trial
The DANFLU-2 trial demonstrates that high-dose influenza vaccine reduces cardiovascular and cardiorespiratory hospitalizations compared to standard-dose in adults ≥65 years, with similar benefits across subgroups including heart failure and
Enhanced Protection in Heart Failure: High-Dose Influenza Vaccine Outperforms Standard Dose in the DANFLU-2 Trial
The DANFLU-2 trial reveals that high-dose influenza vaccine significantly reduces hospitalization for influenza and cardiovascular events in older adults, including those with heart failure, compared to the standard-dose vaccine.
PANDA II Trial Confirms Influenza Vaccination as Essential Intervention for Acute Heart Failure Patients
The PANDA II study demonstrates that influenza vaccination significantly reduces mortality and rehospitalization in acute heart failure patients, supporting its inclusion as a standard component of heart failure management worldwide.
Azelastine Nasal Spray Significantly Reduces SARS-CoV-2 Infection Risk: Results from a Phase 2 Randomized Clinical Trial
This phase 2 trial demonstrates that azelastine nasal spray reduces SARS-CoV-2 infections and symptomatic respiratory illnesses in a healthy, vaccinated adult population, suggesting its potential as a safe, scalable prophylactic measure aga
Evaluating RSV Vaccine Effectiveness Against Hospitalization in US Adults Aged 60 and Older Over Two Seasons
A large multicenter study demonstrates that a single dose of RSV vaccine reduces hospitalization risk by 58% among adults aged 60+, with lower effectiveness in immunocompromised and cardiovascular patients.
Bivalent RSV Prefusion F Protein Vaccine: A Potential Strategy to Reduce Cardiovascular Hospitalizations in Older Adults
The DAN-RSV trial demonstrates that RSV vaccination significantly lowers all-cause cardiorespiratory hospitalizations among older adults, suggesting vaccines may reduce infection-triggered cardiovascular complications and benefit chronic di
Invisible Invaders: How Microplastics Penetrate Our Bodies and What You Can Do About It
Microplastics, tiny plastic particles under 5mm, have silently infiltrated our bodies through drinking water, air, and food. They accumulate in organs, accelerate cell aging, and increase inflammation. Learn hidden sources and practical tip
Invisible Intruders: Microplastics Found in Every Human Placenta Sample Tested
Recent research shows microplastics present in 100% of 62 human placentas analyzed, raising concerns about prenatal exposure and future health implications.
Microwaving Plastic Containers: A Hidden Source of Billions of Microplastic Particles in Your Food
Recent research reveals that microwaving plastic food containers can release billions of micro- and nanoplastic particles into food, posing potential health risks, especially to infants and young children. Understanding this silent contamin
FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults
The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving
Browse by specialty
Open language-specific specialty feeds and department pages.